India · English
Mankind Pharma to acquire 70% in Belgian biotech firm for €48 million
Deal marks entry into next-generation CAR-T cancer therapies as company expands global innovation ambitions
Read the full report at Business Standard →
About this page
AKHBAARI groups the same story across publishers so you can see who is reporting it and how they differ. The summary above is machine-generated from the publisher's own feed text and is labelled as such. The full report stays with the publisher, who holds copyright in it. See our editorial policy.